Drug target identification, validation, characterisation and exploitation for treatment of Acanthamoeba (species) infections.
about
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatmentCellulose degradation: a therapeutic strategy in the improved treatment of Acanthamoeba infectionsDrug discovery and the use of computational approaches for infectious diseases.Microbiological cure times in acanthamoeba keratitis.Complex patterns of gene fission in the eukaryotic folate biosynthesis pathway.In vitro efficacy of corifungin against Acanthamoeba castellanii trophozoites and cysts.
P2860
Drug target identification, validation, characterisation and exploitation for treatment of Acanthamoeba (species) infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Drug target identification, va ...... thamoeba (species) infections.
@en
Drug target identification, va ...... thamoeba (species) infections.
@nl
type
label
Drug target identification, va ...... thamoeba (species) infections.
@en
Drug target identification, va ...... thamoeba (species) infections.
@nl
prefLabel
Drug target identification, va ...... thamoeba (species) infections.
@en
Drug target identification, va ...... thamoeba (species) infections.
@nl
P1476
Drug target identification, va ...... thamoeba (species) infections.
@en
P2093
Fiona L Henriquez
P356
10.1016/J.EXPPARA.2009.11.016
P577
2009-12-24T00:00:00Z